Shares of Hovnanian Enterprises (HOV) were down Friday, after reporting lackluster earnings for its most recent quarter. Results came in at break-even, while analysts had expected $0.06. Revenue was up 32.6 percent year-over-year to $716.9 million, missing the $732.51 million analysts were expecting. As for its fiscal 2016 guidance, the company expects revenue between $2.7 billion and $2.9 billion, while analysts were expecting $2.75 billion. TheStreet's Scott Gamm reports from Wall Street.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.